Cure TV

Safran is the Executive Director of The Identity Shift Project, which aims to bring new perspectives to healing through collaborative art making.

Kay Verble discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).

Karen Duffy pays tribute to her husband, Harvey Lawrence Gould, who was named one of our 2015 MPN Heroes.

Greg Cantwell, a survivor of glioblastoma multiforme (GBM) and the founder of Greg's Mission, discusses the need to support and educate patients with GBM.

Jason R. Gotlib discusses the research being done at his institution. Gotlib is a 2015 MPN Hero in the category of Commitment to the Individual and is also an international leader in MPN research.

David T. Boule discusses the challenges and rewards of patient advocacy.

Sherry Fox accepts her award as one of our 2015 GBM Heroes.

Santosh Kesari discusses the need to think outside the box when conducting research in glioblastoma multiforme (GBM).

Rebecca N. Claassen discusses the importance of educating nurses about myeloproliferative neoplasms (MPNs).

Barbara Van Husen, president, MPN Research Foundation, discusses research into myeloproliferative neoplasms.

David Allen Denny, an administrator of the Myelofibrosis Private Support Group, tells the story of his diagnosis.

Cord blood banking can treat autoimmune disease, immune deficiencies, histiocytosis, leukemias, lymphomas, myelodysplasias and more.

Blake A. Morrison discusses the recent excitement in myeloma research.

Jennifer Arnold, a physician and a star of TLC's reality TV show "The Little Couple," pays tribute to our MPN Heroes.

Award-winning actress and author Valerie Harper pays tribute to CURE's inaugural class of GBM Heroes.

CURE spoke with Wierda at the 2015 Chemotherapy Foundation Symposium, a meeting of over 1,000 oncologists and oncology professionals.

CURE spoke with Gilbert at the 2015 Society for Neuro-Oncology Annual Meeting, a meeting of over 1,000 oncology professionals.

Michael J. Mauro, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

C. Ola Landgren provides an overview of the diagnosis and treatment of smoldering multiple myeloma.

C. Ola Landgren discusses ways to measure response to treatment in multiple myeloma.

Alison Morris, Hematology/Oncology Nurse Practitioner, Stanford Health Care, discusses her hopes for the future of screening for emotional and physical distress.

Alison Morris, Hematology/Oncology Nurse Practitioner, Stanford Health Care, discusses a study looking at screening for emotional and physical distress.

In this segment, David Liu, shares a case study of a 33-year-old woman with stage 4 colorectal cancer that had metastasized to the liver.

Rudolph Navari, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.

Christian J. Nelson, clinical psychologist, Memorial Sloan Kettering Cancer Center, discusses how quality of life changes over time and cancer's effect.

Christian J. Nelson, clinical psychologist, Memorial Sloan Kettering Cancer Center, discusses the treatment of older patients with cancer.

Amanda L. Kong, discusses why patients should consider seeking a second opinion for their breast cancer diagnosis and care at a high volume hospital.